Active DNA demethylation: Many roads lead to Rome

Nature Reviews Molecular Cell Biology

Volumn 11, Issue 9, 2010, Pages 607-620

  Wu, Susan C ^a   Zhang, Yi ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 METHYLCYTOSINE; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 1; B LYMPHOCYTE INDUCED MATURATION PROTEIN 1; BRAIN DERIVED NEUROTROPHIC FACTOR; DNA METHYLTRANSFERASE 1; DNA METHYLTRANSFERASE 3A; DNA METHYLTRANSFERASE 3B; FIBROBLAST GROWTH FACTOR 1; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45; METHYL CPG BINDING PROTEIN; S ADENOSYLMETHIONINE;

CONTROLLED STUDY; DEMETHYLATION; DNA METHYLATION; DNA MODIFICATION; DNA REPLICATION; EMBRYONIC STEM CELL; EPIGENETICS; EXCISION REPAIR; GENE LOCUS; GENE SILENCING; GENETIC REGULATION; GENOME IMPRINTING; HUMAN; NONHUMAN; OXIDATION; PRIMORDIAL GERM CELL; PRIORITY JOURNAL; PRONUCLEUS; REGENERATIVE MEDICINE; REVIEW; SOMATIC CELL; TRANSPOSON; X CHROMOSOME INACTIVATION; ZONA PELLUCIDA;

ANIMALS; DNA METHYLATION; DNA-BINDING PROTEINS; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; PROTO-ONCOGENE PROTEINS;

EID: 77956095231     PISSN: 14710072     EISSN: 14710080     Source Type: Journal    
DOI: 10.1038/nrm2950     Document Type: Review

References (177)

1. Jaenisch, R. & Bird, A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nature Genet. 33, 245-254 (2003).
2. Jenuwein, T. & Allis, C. D. Translating the histone code. Science 293, 1074-1080 (2001).
3. Birney, E. et al. Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature 447, 799-816 (2007).
4. Esteller, M. Cancer epigenomics: DNA methylomes and histone-modification maps. Nature Rev. Genet. 8, 286-298 (2007).
5. Feinberg, A. P. & Tycko, B. The history of cancer epigenetics. Nature Rev. Cancer 4, 143-153 (2004).
6. Pogribny, I. P. & Beland, F. A. DNA hypomethylation in the origin and pathogenesis of human diseases. Cell. Mol. Life Sci. 66, 2249-2261 (2009).
7. Santos-Reboucas, C. B. & Pimentel, M. M. Implication of abnormal epigenetic patterns for human diseases. Eur. J. Hum. Genet. 15, 10-17 (2007).
8. Law, J. A. & Jacobsen, S. E. Establishing, maintaining and modifying DNA methylation patterns in plants and animals. Nature Rev. Genet. 11, 204-220 (2010).
9. Goll, M. G. & Bestor, T. H. Eukaryotic cytosine methyltransferases. Annu. Rev. Biochem. 74, 481-514 (2005).
10. Okano, M., Xie, S. & Li, E. Cloning and characterization of a family of novel mammalian DNA (cytosine-5) methyltransferases. Nature Genet. 19, 219-220 (1998).
11. Okano, M., Bell, D. W., Haber, D. A. & Li, E. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 99, 247-257 (1999).
12. Bestor, T. H. & Ingram, V. M. Two DNA methyltransferases from murine erythroleukemia cells: purification, sequence specificity, and mode of interaction with DNA. Proc. Natl Acad. Sci. USA 80, 5559-5563 (1983).
13. Bestor, T., Laudano, A., Mattaliano, R. & Ingram, V. Cloning and sequencing of a cDNA encoding DNA methyltransferase of mouse cells. The carboxyl-terminal domain of the mammalian enzymes is related to bacterial restriction methyltransferases. J. Mol. Biol. 203, 971-983 (1988).
14. Hermann, A., Goyal, R. & Jeltsch, A. The Dnmt1 DNA-(cytosine-C5)- methyltransferase methylates DNA processively with high preference for hemimethylated target sites. J. Biol. Chem. 279, 48350-48359 (2004).
15. Li, E., Bestor, T. H. & Jaenisch, R. Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell 69, 915-926 (1992).
16. Ooi, S. K. & Bestor, T. H. The colorful history of active DNA demethylation. Cell 133, 1145-1148 (2008).
17. Mayer, W., Niveleau, A., Walter, J., Fundele, R. &Haaf, T. Demethylation of the zygotic paternal genome. Nature 403, 501-502 (2000).
18. Oswald, J. et al. Active demethylation of the paternal genome in the mouse zygote. Curr. Biol. 10, 475-478 (2000). References 17 and 18 report the first observation of genome-wide active DNA demethylation in the paternal pronucleus based on 5meC immunostaining in developing zygotes. Reference 18 also provides bisulphite sequencing evidence for active demethylation.
19. Ajduk, A., Yamauchi, Y. & Ward, M. A. Sperm chromatin remodeling after intracytoplasmic sperm injection differs from that of in vitro fertilization. Biol. Reprod. 75, 442-451 (2006).
20. Aoki, E. & Schultz, R. M. DNA replication in the 1-cell mouse embryo: stimulatory effect of histone acetylation. Zygote 7, 165-172 (1999).
21. Bouniol-Baly, C., Nguyen, E., Besombes, D. & Debey, P. Dynamic organization of DNA replication in one-cell mouse embryos: relationship to transcriptional activation. Exp. Cell Res. 236, 201-211 (1997).
22. Ferreira, J. & Carmo-Fonseca, M. Genome replication in early mouse embryos follows a defined temporal and spatial order. J. Cell Sci. 110, 889-897 (1997).
23. Howlett, S. K. & Bolton, V. N. Sequence and regulation of morphological and molecular events during the first cell cycle of mouse embryogenesis. J. Embryol. Exp. Morphol. 87, 175-206 (1985).
24. Luthardt, F. W. & Donahue, R. P. Pronuclear DNA synthesis in mouse eggs. An autoradiographic study. Exp. Cell Res. 82, 143-151 (1973).
25. Yamauchi, Y., Ward, M. A. & Ward, W. S. Asynchronous DNA replication and origin licensing in the mouse onecell embryo. J. Cell. Biochem. 107, 214-223 (2009).
26. Kishigami, S. et al. Epigenetic abnormalities of the mouse paternal zygotic genome associated with microinsemination of round spermatids. Dev. Biol. 289, 195-205 (2006).
27. Dean, W. et al. Conservation of methylation reprogramming in mammalian development: aberrant reprogramming in cloned embryos. Proc. Natl Acad. Sci. USA 98, 13734-13738 (2001).
28. Fulka, H., Mrazek, M., Tepla, O. & Fulka, J. Jr. DNA methylation pattern in human zygotes and developing embryos. Reproduction 128, 703-708 (2004).
29. Beaujean, N. et al. Non-conservation of mammalian preimplantation methylation dynamics. Curr. Biol. 14, R266-R267 (2004).
30. Beaujean, N. et al. The effect of interspecific oocytes on demethylation of sperm DNA. Proc. Natl Acad. Sci. USA 101, 7636-7640 (2004).
31. Santos, F., Hendrich, B., Reik, W. & Dean, W. Dynamic reprogramming of DNA methylation in the early mouse embryo. Dev. Biol. 241, 172-182 (2002).
32. Barton, S. C. et al. Genome-wide methylation patterns in normal and uniparental early mouse embryos. Hum. Mol. Genet. 10, 2983-2987 (2001).
33. Olek, A. & Walter, J. The pre-implantation ontogeny of the H19 methylation imprint. Nature Genet. 17, 275-276 (1997).
34. Lane, N. et al. Resistance of IAPs to methylation reprogramming may provide a mechanism for epigenetic inheritance in the mouse. Genesis 35, 88-93 (2003).
35. Rougier, N. et al. Chromosome methylation patterns during mammalian preimplantation development. Genes Dev. 12, 2108-2113 (1998).
36. Dean, W., Santos, F. & Reik, W. Epigenetic reprogramming in early mammalian development and following somatic nuclear transfer. Semin. Cell Dev. Biol. 14, 93-100 (2003).
37. Aoki, F., Worrad, D. M. & Schultz, R. M. Regulation of transcriptional activity during the first and second cell cycles in the preimplantation mouse embryo. Dev. Biol. 181, 296-307 (1997).
38. Monk, M., Boubelik, M. & Lehnert, S. Temporal and regional changes in DNA methylation in the embryonic, extraembryonic and germ cell lineages during mouse embryo development. Development 99, 371-382 (1987).
39. Howlett, S. K. & Reik, W. Methylation levels of maternal and paternal genomes during preimplantation development. Development 113, 119-127 (1991).
40. Carlson, L. L., Page, A. W. & Bestor, T. H. Properties and localization of DNA methyltransferase in preimplantation mouse embryos: implications for genomic imprinting. Genes Dev. 6, 2536-2541 (1992).
41. Hirasawa, R. et al. Maternal and zygotic Dnmt1 are necessary and sufficient for the maintenance of DNA methylation imprints during preimplantation development. Genes Dev. 22, 1607-1616 (2008).
42. Li, X. et al. A maternal-zygotic effect gene, Zfp57, maintains both maternal and paternal imprints. Dev. Cell 15, 547-557 (2008).
43. Ohinata, Y. et al. A signaling principle for the specification of the germ cell lineage in mice. Cell 137, 571-584 (2009).
44. Saitou, M. Germ cell specification in mice. Curr. Opin. Genet. Dev. 19, 386-395 (2009).
45. Hajkova, P. et al. Epigenetic reprogramming in mouse primordial germ cells. Mech. Dev. 117, 15-23 (2002). The authors report rapid loss of DNA methylation in PGCs during their migration through the genital ridge.
46. Lee, J. et al. Erasing genomic imprinting memory in mouse clone embryos produced from day 11.5 primordial germ cells. Development 129, 1807-1817 (2002).
47. Yamazaki, Y. et al. Reprogramming of primordial germ cells begins before migration into the genital ridge, making these cells inadequate donors for reproductive cloning. Proc. Natl Acad. Sci. USA 100, 12207-12212 (2003).
48. Bruniquel, D. & Schwartz, R. H. Selective, stable demethylation of the interleukin-2 gene enhances transcription by an active process. Nature Immunol. 4, 235-240 (2003).
49. Martinowich, K. et al. DNA methylation-related chromatin remodeling in activity-dependent BDNF gene regulation. Science 302, 890-893 (2003).
50. Kangaspeska, S. et al. Transient cyclical methylation of promoter DNA. Nature 452, 112-115 (2008).
51. Metivier, R. et al. Cyclical DNA methylation of a transcriptionally active promoter. Nature 452, 45-50 (2008). References 50 and 51 report that transcriptional cycling on activation by oestrogens coincides with periodic rounds of promoter methylation and demethylation of pS2. The demethylation process correlates with the recruitment of certain repair proteins.
52. Kim, M. S. et al. DNA demethylation in hormoneinduced transcriptional derepression. Nature 461, 1007-1012 (2009).
53. Gjerset, R. A. & Martin, D. W. Jr. Presence of a DNA demethylating activity in the nucleus of murine erythroleukemic cells. J. Biol. Chem. 257, 8581-8583 (1982).
54. Weiss, A., Keshet, I., Razin, A. & Cedar, H. DNA demethylation in vitro: involvement of RNA. Cell 86, 709-718 (1996).
55. Swisher, J. F., Rand, E., Cedar, H. & Marie Pyle, A. Analysis of putative RNase sensitivity and protease insensitivity of demethylation activity in extracts from rat myoblasts. Nucleic Acids Res. 26, 5573-5580 (1998).
56. Bhattacharya, S. K., Ramchandani, S., Cervoni, N. &Szyf, M. A mammalian protein with specific demethylase activity for mCpG DNA. Nature 397, 579-583 (1999).
57. Ng, H. H. et al. MBD2 is a transcriptional repressor belonging to the MeCP1 histone deacetylase complex. Nature Genet. 23, 58-61 (1999).
58. Hendrich, B. & Bird, A. Identification and characterization of a family of mammalian methyl-CpG binding proteins. Mol. Cell. Biol. 18, 6538-6547 (1998).
59. Hendrich, B., Guy, J., Ramsahoye, B., Wilson, V. A. &Bird, A. Closely related proteins MBD2 and MBD3 play distinctive but interacting roles in mouse development. Genes Dev. 15, 710-723 (2001).
60. Klose, R. J., Kallin, E. M. & Zhang, Y. JmjC-domain-containing proteins and histone demethylation. Nature Rev. Genet. 7, 715-727 (2006).
61. Klose, R. J. & Zhang, Y. Regulation of histone methylation by demethylimination and demethylation. Nature Rev. Mol. Cell Biol. 8, 307-318 (2007).
62. Smiley, J. A., Kundracik, M., Landfried, D. A., Barnes, V. R. Sr & Axhemi, A. A. Genes of the thymidine salvage pathway: thymine-7-hydroxylase from a Rhodotorula glutinis cDNA library and iso-orotate decarboxylase from Neurospora crassa. Biochim. Biophys. Acta 1723, 256-264 (2005).
63. Lepesheva, G. I. & Waterman, M. R. Sterol 14α-demethylase cytochrome P450 (CYP51), a P450 in all biological kingdoms. Biochim. Biophys. Acta 1770, 467-477 (2007).
64. Sancar, A., Lindsey-Boltz, L. A., Unsal-Kacmaz, K. &Linn., S. Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu. Rev. Biochem. 73, 39-85 (2004).
65. Zhu, J. K. Active DNA demethylation mediated by DNA glycosylases. Annu. Rev. Genet. 43, 143-166 (2009).
66. Choi, Y. et al. DEMETER, a DNA glycosylase domain protein, is required for endosperm gene imprinting and seed viability in Arabidopsis. Cell 110, 33-42 (2002).
67. Gong, Z. et al. ROS1, a repressor of transcriptional gene silencing in Arabidopsis, encodes a DNA glycosylase/lyase. Cell 111, 803-814 (2002).
68. Agius, F., Kapoor, A. & Zhu, J. K. Role of the Arabidopsis DNA glycosylase/lyase ROS1 in active DNA demethylation. Proc. Natl Acad. Sci. USA 103, 11796-11801 (2006).
69. Gehring, M. et al. DEMETER DNA glycosylase establishes MEDEA polycomb gene self-imprinting by allele-specific demethylation. Cell 124, 495-506 (2006).
70. Morales-Ruiz, T. et al. DEMETER and REPRESSOR OF SILENCING 1 encode 5-methylcytosine DNA glycosylases. Proc. Natl Acad. Sci. USA 103, 6853-6858 (2006). Together with references 68, shows that ROS1 possesses 5meC glycosylase activity, and together with reference 69, shows that DME is also an active 5meC glycosylase.
71. Penterman, J. et al. DNA demethylation in the Arabidopsis genome. Proc. Natl Acad. Sci. USA 104, 6752-6757 (2007).
72. Gehring, M., Bubb, K. L. & Henikoff, S. Extensive demethylation of repetitive elements during seed development underlies gene imprinting. Science 324, 1447-1451 (2009).
73. Ortega-Galisteo, A. P., Morales-Ruiz, T., Ariza, R. R. &Roldan-Arjona, T. Arabidopsis DEMETER-LIKE proteins DML2 and DML3 are required for appropriate distribution of DNA methylation marks. Plant Mol. Biol. 67, 671-681 (2008).
74. Jost, J. P. Nuclear extracts of chicken embryos promote an active demethylation of DNA by excision repair of 5-methyldeoxycytidine. Proc. Natl Acad. Sci. USA 90, 4684-4688 (1993).
75. Jost, J. P., Siegmann, M., Sun, L. & Leung, R. Mechanisms of DNA demethylation in chicken embryos. Purification and properties of a 5-methylcytosine-DNA glycosylase. J. Biol. Chem. 270, 9734-9739 (1995).
76. Fremont, M. et al. Demethylation of DNA by purified chick embryo 5-methylcytosine-DNA glycosylase requires both protein and RNA. Nucleic Acids Res. 25, 2375-2380 (1997). (Pubitemid 27303696)
77. Jost, J. P. et al. A chicken embryo protein related to the mammalian DEAD box protein p68 is tightly associated with the highly purified protein-RNA complex of 5-MeC-DNA glycosylase. Nucleic Acids Res. 27, 3245-3252 (1999).
78. Zhu, B. et al. 5-methylcytosine-DNA glycosylase activity is present in a cloned G/T mismatch DNA glycosylase associated with the chicken embryo DNA demethylation complex. Proc. Natl Acad. Sci. USA 97, 5135-5139 (2000).
79. Bennett, M. T. et al. Specificity of human thymine DNA glycosylase depends on N-glycosidic bond stability. J. Am. Chem. Soc. 128, 12510-12519 (2006).
80. Boland, M. J. & Christman, J. K. Characterization of Dnmt3b:thymine-DNA glycosylase interaction and stimulation of thymine glycosylase-mediated repair by DNA methyltransferase(s) and RNA. J. Mol. Biol. 379, 492-504 (2008).
81. Li, Y. Q., Zhou, P. Z., Zheng, X. D., Walsh, C. P. &Xu, G. L. Association of Dnmt3a and thymine DNA glycosylase links DNA methylation with base-excision repair. Nucleic Acids Res. 35, 390-400 (2007).
82. Zhu, B. et al. 5-Methylcytosine DNA glycosylase activity is also present in the human MBD4 (G/T mismatch glycosylase) and in a related avian sequence. Nucleic Acids Res. 28, 4157-4165 (2000).
83. Santos, F. & Dean, W. Epigenetic reprogramming during early development in mammals. Reproduction 127, 643-651 (2004).
84. Millar, C. B. et al. Enhanced CpG mutability and tumorigenesis in MBD4-deficient mice. Science 297, 403-405 (2002).
85. Hendrich, B., Hardeland, U., Ng, H. H., Jiricny, J. &Bird, A. The thymine glycosylase MBD4 can bind to the product of deamination at methylated CpG sites. Nature 401, 301-304 (1999).
86. Conticello, S. G. The AID/APOBEC family of nucleic acid mutators. Genome Biol. 9, 229 (2008).
87. Navaratnam, N. et al. The p27 catalytic subunit of the apolipoprotein B mRNA editing enzyme is a cytidine deaminase. J. Biol. Chem. 268, 20709-20712 (1993).
88. Teng, B., Burant, C. F. & Davidson, N. O. Molecular cloning of an apolipoprotein B messenger RNA editing protein. Science 260, 1816-1819 (1993).
89. Muramatsu, M. et al. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 102, 553-563 (2000).
90. Revy, P. et al. Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2). Cell 102, 565-575 (2000).
91. Morgan, H. D., Dean, W., Coker, H. A., Reik, W. &Petersen-Mahrt, S. K. Activation-induced cytidine deaminase deaminates 5-methylcytosine in DNA and is expressed in pluripotent tissues: implications for epigenetic reprogramming. J. Biol. Chem. 279, 52353-52360 (2004).
92. Popp, C. et al. Genome-wide erasure of DNA methylation in mouse primordial germ cells is affected by AID deficiency. Nature 463, 1101-1105 (2010). By using high-throughput bisulphite sequencing, the authors show that knockout of AID results in reduced DNA demethylation in PGCs.
93. Rai, K. et al. DNA demethylation in zebrafish involves the coupling of a deaminase, a glycosylase, and GADD45. Cell 135, 1201-1212 (2008). Using zebrafish embryos, the authors show that an injected methylated substrate can be demethylated through the cooperative action of a deaminase (AID), a T glycosylase (MBD4) and GADD45A.
94. Hirano, K. et al. Targeted disruption of the mouse apobec-1 gene abolishes apolipoprotein B mRNA editing and eliminates apolipoprotein B48. J. Biol. Chem. 271, 9887-9890 (1996).
95. Morrison, J. R. et al. Apolipoprotein B RNA editing enzyme-deficient mice are viable despite alterations in lipoprotein metabolism. Proc. Natl Acad. Sci. USA 93, 7154-7159 (1996).
96. Bandaru, B., Wyszynski, M. & Bhagwat, A. S. HpaII methyltransferase is mutagenic in Escherichia coli. J. Bacteriol. 177, 2950-2952 (1995).
97. Shen, J. C., Rideout, W. M. 3rd & Jones, P. A. High frequency mutagenesis by a DNA methyltransferase. Cell 71, 1073-1080 (1992).
98. Zingg, J. M., Shen, J. C., Yang, A. S., Rapoport, H. &Jones, P. A. Methylation inhibitors can increase the rate of cytosine deamination by (cytosine-5)-DNA methyltransferase. Nucleic Acids Res. 24, 3267-3275 (1996).
99. Wyszynski, M., Gabbara, S. & Bhagwat, A. S. Cytosine deaminations catalyzed by DNA cytosine methyltransferases are unlikely to be the major cause of mutational hot spots at sites of cytosine methylation in Escherichia coli. Proc. Natl Acad. Sci. USA 91, 1574-1578 (1994).
100. Yebra, M. J. & Bhagwat, A. S. A cytosine methyltransferase converts 5-methylcytosine in DNA to thymine. Biochemistry 34, 14752-14757 (1995).
101. Chen, D. et al. T:G mismatch-specific thymine-DNA glycosylase potentiates transcription of estrogenregulated genes through direct interaction with estrogen receptor α. J. Biol. Chem. 278, 38586-38592 (2003).
102. Jost, J. P., Thiry, S. & Siegmann, M. Estradiol receptor potentiates, in vitro, the activity of 5-methylcytosine DNA glycosylase. FEBS Lett. 527, 63-66 (2002).
103. Barreto, G. et al. Gadd45a promotes epigenetic gene activation by repair-mediated DNA demethylation. Nature 445, 671-675 (2007).
104. Zhan, Q. Gadd45a, a p53-and BRCA1-regulated stress protein, in cellular response to DNA damage. Mutat. Res. 569, 133-143 (2005).
105. Smith, M. L. et al. Interaction of the p53-regulated protein Gadd45 with proliferating cell nuclear antigen. Science 266, 1376-1380 (1994).
106. Smith, M. L. et al. Antisense GADD45 expression results in decreased DNA repair and sensitizes cells to UV-irradiation or cisplatin. Oncogene 13, 2255-2263 (1996).
107. Schmitz, K. M. et al. TAF12 recruits Gadd45a and the nucleotide excision repair complex to the promoter of rRNA genes leading to active DNA demethylation. Mol. Cell 33, 344-353 (2009).
108. Jin, S. G., Guo, C. & Pfeifer, G. P. GADD45A does not promote DNA demethylation. PLoS Genet. 4, e1000013 (2008).
109. Engel, N. et al. Conserved DNA methylation in Gadd45a-/-mice. Epigenetics 4, 98-99 (2009).
110. Ma, D. K. et al. Neuronal activity-induced Gadd45b promotes epigenetic DNA demethylation and adult neurogenesis. Science 323, 1074-1077 (2009).
111. Okada, Y., Yamagata, K., Hong, K., Wakayama, T. &Zhang, Y. A role for the elongator complex in zygotic paternal genome demethylation. Nature 463, 554-558 (2010).
112. Falnes, P. O., Johansen, R. F. & Seeberg, E. AlkBmediated oxidative demethylation reverses DNA damage in Escherichia coli. Nature 419, 178-182 (2002).
113. Trewick, S. C., Henshaw, T. F., Hausinger, R. P., Lindahl, T. & Sedgwick, B. Oxidative demethylation by Escherichia coli AlkB directly reverts DNA base damage. Nature 419, 174-178 (2002).
114. Tsukada, Y. et al. Histone demethylation by a family of JmjC domain-containing proteins. Nature 439, 811-816 (2006).
115. Warn-Cramer, B. J., Macrander, L. A. & Abbott, M. T. Markedly different ascorbate dependencies of the sequential α-ketoglutarate dioxygenase reactions catalyzed by an essentially homogeneous thymine 7-hydroxylase from Rhodotorula glutinis. J. Biol. Chem. 258, 10551-10557 (1983).
116. Cliffe, L. J. et al. JBP1 and JBP2 are two distinct thymidine hydroxylases involved in J biosynthesis in genomic DNA of African trypanosomes. Nucleic Acids Res. 37, 1452-1462 (2009).
117. Yu, Z. et al. The protein that binds to DNA base J in trypanosomatids has features of a thymidine hydroxylase. Nucleic Acids Res. 35, 2107-2115 (2007).
118. Tahiliani, M. et al. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 324, 930-935 (2009).
119. Ito, S. et al. Role of Tet proteins in 5mC to 5hmC conversion, ES cell self-renewal, and ICM specification. Nature 18 Jul 2010 (doi:10.1038/ nature09303).
120. Lorsbach, R. B. et al. TET1, a member of a novel protein family, is fused to MLL in acute myeloid leukemia containing the t(10;11)(q22;q23). Leukemia 17, 637-641 (2003).
121. Ono, R. et al. LCX, leukemia-associated protein with a CXXC domain, is fused to MLL in acute myeloid leukemia with trilineage dysplasia having t(10;11) (q22;q23). Cancer Res. 62, 4075-4080 (2002).
122. Penn, N. W., Suwalski, R., O'Riley, C., Bojanowski, K. &Yura, R. The presence of 5-hydroxymethylcytosine in animal deoxyribonucleic acid. Biochem. J. 126, 781-790 (1972).
123. Kothari, R. M. & Shankar, V. 5-Methylcytosine content in the vertebrate deoxyribonucleic acids: species specificity. J. Mol. Evol. 7, 325-329 (1976).
124. Kriaucionis, S. & Heintz, N. The nuclear DNA base 5-hydroxymethylcytosine is present in Purkinje neurons and the brain. Science 324, 929-930 (2009).
125. Jin, S. G., Kadam, S. & Pfeifer, G. P. Examination of the specificity of DNA methylation profiling techniques towards 5-methylcytosine and 5-hydroxymethylcytosine. Nucleic Acids Res. 38, e125 (2010).
126. Valinluck, V. et al. Oxidative damage to methyl-CpG sequences inhibits the binding of the methyl-CpG binding domain (MBD) of methyl-CpG binding protein 2 (MeCP2). Nucleic Acids Res. 32, 4100-4108 (2004).
127. Valinluck, V. & Sowers, L. C. Endogenous cytosine damage products alter the site selectivity of human DNA maintenance methyltransferase DNMT1. Cancer Res. 67, 946-950 (2007).
128. Cannon, S. V., Cummings, A. & Teebor, G. W. 5-Hydroxymethylcytosine DNA glycosylase activity in mammalian tissue. Biochem. Biophys. Res. Commun. 151, 1173-1179 (1988).
129. Boorstein, R. J. et al. Definitive identification of mammalian 5-hydroxymethyluracil DNA N-glycosylase activity as SMUG1. J. Biol. Chem. 276, 41991-41997 (2001).
130. Privat, E. & Sowers, L. C. Photochemical deamination and demethylation of 5-methylcytosine. Chem. Res. Toxicol. 9, 745-750 (1996).
131. Alegria, A. H. Hydroxymethylation of pyrimidine mononucleotides with formaldehyde. Biochim. Biophys. Acta 149, 317-324 (1967).
132. Liutkeviciute, Z., Lukinavicius, G., Masevicius, V., Daujotyte, D. & Klimasauskas, S. Cytosine-5-methyltransferases add aldehydes to DNA. Nature Chem. Biol. 5, 400-402 (2009).
133. Abdel-Wahab, O. et al. Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies. Blood 114, 144-147 (2009).
134. Delhommeau, F. et al. Mutation in TET2 in myeloid cancers. N. Engl. J. Med. 360, 2289-2301 (2009).
135. Jankowska, A. M. et al. Loss of heterozygosity 4q24 and TET2 mutations associated with myelodysplastic/myeloproliferative neoplasms. Blood 113, 6403-6410 (2009).
136. Kosmider, O. et al. TET2 mutation is an independent favorable prognostic factor in myelodysplastic syndromes (MDSs). Blood 114, 3285-3291 (2009).
137. Langemeijer, S. M. et al. Acquired mutations in TET2 are common in myelodysplastic syndromes. Nature Genet. 41, 838-842 (2009).
138. Mohamedali, A. M. et al. Novel TET2 mutations associated with UPD4q24 in myelodysplastic syndrome. J. Clin. Oncol. 27, 4002-4006 (2009).
139. Saint-Martin, C. et al. Analysis of the ten-eleven translocation 2 (TET2) gene in familial myeloproliferative neoplasms. Blood 114, 1628-1632 (2009).
140. Tefferi, A. et al. Detection of mutant TET2 in myeloid malignancies other than myeloproliferative neoplasms: CMML, MDS, MDS/MPN and AML. Leukemia 23, 1343-1345 (2009).
141. Nolte, F. & Hofmann, W. K. Myelodysplastic syndromes: molecular pathogenesis and genomic changes. Ann. Hematol. 87, 777-795 (2008).
142. Daskalakis, M. et al. Demethylation of a hypermethylated P15/INK4B gene in patients with myelodysplastic syndrome by 5-Aza-2′-deoxycytidine (decitabine) treatment. Blood 100, 2957-2964 (2002).
143. Silverman, L. R. et al. Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: a study of the cancer and leukemia group B. J. Clin. Oncol. 20, 2429-2440 (2002).
144. Allen, M. D. et al. Solution structure of the nonmethyl-CpG-binding CXXC domain of the leukaemia-associated MLL histone methyltransferase. EMBO J. 25, 4503-4512 (2006).
145. Hawkes, N. A. et al. Purification and characterization of the human elongator complex. J. Biol. Chem. 277, 3047-3052 (2002).
146. Kim, J. H., Lane, W. S. & Reinberg, D. Human elongator facilitates RNA polymerase II transcription through chromatin. Proc. Natl Acad. Sci. USA 99, 1241-1246 (2002).
147. Greenwood, C., Selth, L. A., Dirac-Svejstrup, A. B. &Svejstrup, J. Q. An iron-sulfur cluster domain in Elp3 important for the structural integrity of elongator. J. Biol. Chem. 284, 141-149 (2009).
148. Li, Q. et al. The elongator complex interacts with PCNA and modulates transcriptional silencing and sensitivity to DNA damage agents. PLoS Genet. 5, e1000684 (2009).
149. Paraskevopoulou, C., Fairhurst, S. A., Lowe, D. J., Brick, P. & Onesti, S. The elongator subunit Elp3 contains a Fe4S4 cluster and binds S-adenosylmethionine. Mol. Microbiol. 59, 795-806 (2006).
150. Cokus, S. J. et al. Shotgun bisulphite sequencing of the Arabidopsis genome reveals DNA methylation patterning. Nature 452, 215-219 (2008).
151. Li, M. et al. Sensitive digital quantification of DNA methylation in clinical samples. Nature Biotechnol. 27, 858-863 (2009).
152. Zilberman, D., Gehring, M., Tran, R. K., Ballinger, T. &Henikoff, S. Genome-wide analysis of Arabidopsis thaliana DNA methylation uncovers an interdependence between methylation and transcription. Nature Genet. 39, 61-69 (2007).
153. Lister, R. et al. Highly integrated single-base resolution maps of the epigenome in Arabidopsis. Cell 133, 523-536 (2008).
154. Flusberg, B. A. et al. Direct detection of DNA methylation during single-molecule, real-time sequencing. Nature Methods 7, 461-465 (2010).
155. Jones, P. A. & Baylin, S. B. The fundamental role of epigenetic events in cancer. Nature Rev. Genet. 3, 415-428 (2002).
156. Gal-Yam, E. N., Saito, Y., Egger, G. & Jones, P. A. Cancer epigenetics: modifications, screening, and therapy. Annu. Rev. Med. 59, 267-280 (2008).
157. Karberg, S. Switching on epigenetic therapy. Cell 139, 1029-1031 (2009).
158. Torres-Padilla, M. E., Bannister, A. J., Hurd, P. J., Kouzarides, T. & Zernicka-Goetz, M. Dynamic distribution of the replacement histone variant H3.3 in the mouse oocyte and preimplantation embryos. Int. J. Dev. Biol. 50, 455-461 (2006).
159. Van Der Heijden, G. W. et al. Asymmetry in histone H3 variants and lysine methylation between paternal and maternal chromatin of the early mouse zygote. Mech. Dev. 122, 1008-1022 (2005).
160. Arney, K. L., Bao, S., Bannister, A. J., Kouzarides, T. &Surani, M. A. Histone methylation defines epigenetic asymmetry in the mouse zygote. Int. J. Dev. Biol. 46, 317-320 (2002).
161. Cowell, I. G. et al. Heterochromatin, HP1 and methylation at lysine 9 of histone H3 in animals. Chromosoma 111, 22-36 (2002).
162. Liu, H., Kim, J. M. & Aoki, F. Regulation of histone H3 lysine 9 methylation in oocytes and early preimplantation embryos. Development 131, 2269-2280 (2004).
163. Santos, F., Peters, A. H., Otte, A. P., Reik, W. &Dean, W. Dynamic chromatin modifications characterise the first cell cycle in mouse embryos. Dev. Biol. 280, 225-236 (2005).
164. Erhardt, S. et al. Consequences of the depletion of zygotic and embryonic enhancer of zeste 2 during preimplantation mouse development. Development 130, 4235-4248 (2003).
165. Nakamura, T. et al. PGC7/Stella protects against DNA demethylation in early embryogenesis. Nature Cell Biol. 9, 64-71 (2007).
166. Payer, B. et al. Stella is a maternal effect gene required for normal early development in mice. Curr. Biol. 13, 2110-2117 (2003).
167. Takahashi, K. et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861-872 (2007).
168. Takahashi, K. & Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663-676 (2006).
169. Gidekel, S. & Bergman, Y. A unique developmental pattern of Oct-3/4 DNA methylation is controlled by a cis-demodification element. J. Biol. Chem. 277, 34521-34530 (2002).
170. Hattori, N. et al. Epigenetic regulation of Nanog gene in embryonic stem and trophoblast stem cells. Genes Cells 12, 387-396 (2007).
171. Hattori, N. et al. Epigenetic control of mouse Oct?4 gene expression in embryonic stem cells and trophoblast stem cells. J. Biol. Chem. 279, 17063-17069 (2004).
172. Li, J. Y. et al. Synergistic function of DNA methyltransferases Dnmt3a and Dnmt3b in the methylation of Oct4 and Nanog. Mol. Cell Biol. 27, 8748-8759 (2007).
173. Mikkelsen, T. S. et al. Dissecting direct reprogramming through integrative genomic analysis. Nature 454, 49-55 (2008).
174. Han, D. W. et al. Pluripotential reprogramming of the somatic genome in hybrid cells occurs with the first cell cycle. Stem Cells 26, 445-454 (2008).
175. Tada, M., Takahama, Y., Abe, K., Nakatsuji, N. &Tada, T. Nuclear reprogramming of somatic cells by in vitro hybridization with ES cells. Curr. Biol. 11, 1553-1558 (2001).
176. Hanna, J. et al. Direct cell reprogramming is a stochastic process amenable to acceleration. Nature 462, 595-601 (2009).
177. Bhutani, N. et al. Reprogramming towards pluripotency requires AID-dependent DNA demethylation. Nature 463, 1042-1047 (2010).